CZ129597A3 - Process for preparing small particles - Google Patents
Process for preparing small particles Download PDFInfo
- Publication number
- CZ129597A3 CZ129597A3 CZ971295A CZ129597A CZ129597A3 CZ 129597 A3 CZ129597 A3 CZ 129597A3 CZ 971295 A CZ971295 A CZ 971295A CZ 129597 A CZ129597 A CZ 129597A CZ 129597 A3 CZ129597 A3 CZ 129597A3
- Authority
- CZ
- Czechia
- Prior art keywords
- quot
- pct
- small particles
- date
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Saccharide Compounds (AREA)
- Confectionery (AREA)
- Soft Magnetic Materials (AREA)
- Surgical Instruments (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Description
• ·
•Λ.
v V -i i; : . \KV . i v'.* _ i 11 :\ v • I * · • · · • m * * · • * * « * · · · • * · · • ·
• · · **» * »· * v rr. ; Iv:·?. v·:-. l·'
v,-.- ·. .L jclS Ι \\ v\ i v
i ·· O 'O I : :\ n Κ : rcy l! Iř
V
í I
Viil·"’'' - -ίΐ'ί: i. : ' i ! ΙΊ i1.'.'1, .-',V i'· \ ΪΊΜΑ Va VOC, 1 ! V C f! i í , :'a’ r:1 ·ν·! vaa r11 . nábo;;i‘-‘M: 1 ; :: ar ažan i ria i I : v-' AÍ:'t .. r: v. a i o 1 v·.' k f'. r o s ť- .-a t. ] i ’ K v T::á:; i aa i.'ar:r.lavvrr, v y ; κ v \ Μ Μ • · · • * · · * · · · • I « · Μ * · ν • · • · * · • · I * · * * ψ · · · t· É · * 'V: ν ν!·\ \
V v vkv i. i.; V Μ :ι
Vy' \·· r.' i'i\’ ;V:ííC ]: ' . \· i:· V ' V' ’ J . ;] V v;·1 ' VV vy να r i. iv . λ·· i r
I , ' 1 i. V 1 T V \ rn vy V W V V '[ V1 v :vi r u . v
VWlY vci!' 'i a V::,· ' νγνη ..jer Y'V V1 i-’!!·: ,j I ; ; ;'J ; j ' ; ; O i y! 1 Ir^" Ol1' ; : v 4
v i Ίί:'-: !iV'iřoÍ'.'b; kfvry vy 1 :'ιν':Γ n-i : ;-u'; vy k u nahrnu]o v-vvv; '-kut- lc · ji.· j i;:;·; v ..a í ; ίο vuivnoria i !v "jvΓ!r r ar' ; nu r ομΟ.Ί i: p.n; yri'n T / .nín ί í j Ϊ mi v oivrun ar u fit s.' ; ' >"*.[ \ V' -LÍTÁ' , km-rv nahrnu
• I Μ (] » * • ··· » · · • * * Μ *♦ · » * • *
Γ\ r- Γ ^ Γ: ! : i ^ 1.!1.Ji : ' 1 . !\ Γ" 1 ο Γ ·ΐλ Υ ΓΓ1 ! J . γ;· ·:. .ι ^ , <·ΊΥ j „·1 1 j_ V : [. ! Μ .1 1 U : : ί\ Υ ι * Ο ' ’ ι. V · J i - ϊτί Γ i .L J i Γ k ' ’VV : u \\' ' ip
V : \ 'V v
v VI
P t.UD \ po;·i ppi L li fJ i - ' k Ί } ťCílloho kv
lvi'
r,i Ti: ] 'P
..VVPPIPP : 11 j p; pp.i : e r o π r; i, 7 7 II II • * » • I Μ· • * · · I · · I • V Μ ** Μ ···* • I · * • · * · • « I·· · • · · • * ·* *
V'. i : 'j ά zk lir;,; i η 0:.1 Vť-· .<.· i [i-:.· v. v or ,r v pvdi.e vyveleyu je ;. :ρ· mš ·:'"Ί . .v , :W' einde r .v : ; ve které ' '-y · M '! V K .í -'!!.ě V, které j ]!'. V--i ·..! OV ,t: : j V poměrné - 1 i K : j- i ] ' O L ; V' "íl i ] kii i í I··1 . ‘ d Μ í . ;V' íí V'e j >: i :j v L V - .1 t? í íi . Μϋν. .V 'V : Τ' π Γ ; ι.·:ί |"íi" 1 , , e ÍVi W i , ! , e Γ.·1'1 T O V i", ó W V I,' >Π , í i v ; ; ;viv i <!, a ave [ -a i. t r i ! , : ’ i!: :V ?. . V . · Li V i, Cjr; 1 eiI WCI 1 V i \řV: ια 1 θ': U ů
V K.
V k
Hivvenv : V / i VeteV i.v 1 v k ;y , ve; vy i ce i :ι I o z a vn a v v c l egeervin , V’.' ; r.v i i y ! r '.v i dev :: váty ve ! ; :\w Λγ:. : opy diietkv i ve j v I tca; :>d a a : .· V , ví. i r d >.i i v··· e;Ί i e i i ·; : ·ί;γ i ; vedny a chiori. id i r'i i :.ý ·· « ·· • • • · ♦ • • ··« • • · • • f 1 • « » • « * • • ·· ·«» ♦ · ·· ·**» v I ' ι ·. τ' ' Ο !.j ί ' ; 1 : ' Ο Γ V -'XVJ; .‘t;.: jV .1 enové dor ' v-l .. o v rr> ή .v t rj v' ·;- i' i .< v s θ l i ri, V : 'jvh c i n i o ] a ·. ·Ί X Γ.·"· O i IV ! ři X č . ·. "vy o uj i X' . v j. o k .oo \ i; Lo,". Γ. 1' O-!- 1 KΊ Γ;T. , ·."i O! v.-·
ΟΙ ΟΠΊ Ί. O o:ik'.· hydrof .ilní οί'Ί, ;jok. í i.yo :í !γκο i , Γ::
V1 Oo-O
V V ] i cí J. O
ί. '..Ό V OK i ko r y jo o! ;v r ovo; i \o ! O v j Ί 1 ! J. k V O 0 v.·· 1 J t i , >!uor :'.o vysokou i'.V : .i v o ' γ v i; :v - Oy r ' i L V 1 - O i ř ! 1 V K . 1 .. V ' i J : VO : : i V J '" I I 0 : V K ' I V1, U u 0 o ! l ' ! .V ' o l i i V K i i. 0 , o u . íKU.
V V
I v · ': ·\ v i . \ ΜΛ Μ ΜΛ
V i I : i I L- 99 ·· • 99 99 9 9 * * • ·♦ · * 9 · • · • · · t · 9 • * • · • · Ψ • « * 9 999 9 * · * · • · · 9 9 99 • · • 9* M 9 9 ; ί“. ’ i i'.η, 5 r b i r a η eí·; ϊ.μ τ u
.'.Mi L 1 1 1 V xye‘ ! :y : MM'..'V : ν ,ι'.ν v .. t- r,y
MM y k v ; i v oivnira vt I M r '\ 1
Vy.M 'Kr 11.’· L \U’:i i ; íaMV1' M Ti
v .MjM·.-M f i.lílIMMi.>i '.Midi i ckb miiimmÍ MM ; mmm , k Mm I M v vc
'1 1 r
R V 1 i :i V"v *» • ·· »« • • • *· • • • t * • «·« • Φ • • · • • « · · Φ • • * ·#· * • • · • » * ♦ ·· ·· • M ·· ·· R le i' o u J Vfl I. íf! ' ť. I I I V v i ! iV : pY ' !' - : i 1 : ; : RΛ' i.;' . i 1' v i Γ' t r II; V-.lLi r ér :VTn ; V V i i V 1 1 >v rv r ·ί í R' 1' Iv í 1 1 ,
Vi'l i V1";1 .1 1ΊΟ
: V ii - * v i, i V R ' i , R : >J r v OV i IR ’’ i.;'1 i: R VR.1'."! 'V ; .: i ,.;rv :;, ;V; '1; s-.áidh
R : V Y:
I
ν ί -· ·ν
V V ' -J i u Ο Κ ’ ι Γ;· .-V\· ι »» ♦· • I · • · 9 99 • * « « · • « * · • I 99 ·«
9 • 9 1 -.Λ1 ννΓίΐΓ λ; Μ ΙΜ* I · * • · · • t * · • · • · * j: c-
Claims (1)
14 :.vv ;ii'i : V Γ\ I í’1 κ.· - r v v \·1Ί: -f ř an r. n íj h i Γ Γ V \ '1 i: 1 , i t: ·' '[ · ί ·Ί..-:i.V-i : V1;';, · · · » * · > t *· · » 4 4 · I # 4 4 44 44 4 Μ • a · • · * 4 4 · 4 · t «4 ην »4 «444 4 4 4 4 4 4 4 4 44 444 4 ! O V' '\V * i. ; η: j ' ‘ r.' k i v v·:, i : v. r η v.·. M ·· t « · • » ·*·· * « «» * « • · • • · ··· • • 1 « * • • · • t i • ft « ♦ ··* • • # • · * • · » « »· *· *
:·:ί·Γ··' - : < " ' ^··· · "ο·: Ό ο ' : "..'i _ o ook ke.r όί i·...· o' o do.-: i ý V: namokli, ' v' i i i · Ί' , ko o·'.-1 ví o.: r .1 :[: i Γ ; ’ ' !.-:ou vmí^ériy Γ '4; i 1 J i ; vy 1 iy I . Γ I C1 Ti J.í Λ k'j srfíf-r. .1 . 1 j\ I..I v\ 1 , \'V. 'KV iu' i nu. ;; .-i v>i ic:-1! 1 i ; :í· 1 i r.·irr,- l ..v' 1 < 1 r. i VOliY rlár ok ů
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403846A SE9403846D0 (sv) | 1994-11-09 | 1994-11-09 | Small particle formation |
PCT/SE1995/001302 WO1996014833A1 (en) | 1994-11-09 | 1995-11-03 | Small particle formation |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ129597A3 true CZ129597A3 (en) | 1997-12-17 |
Family
ID=20395907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ971295A CZ129597A3 (en) | 1994-11-09 | 1995-11-03 | Process for preparing small particles |
Country Status (27)
Country | Link |
---|---|
US (1) | US5780062A (cs) |
EP (1) | EP0788350B1 (cs) |
JP (1) | JP4098827B2 (cs) |
KR (1) | KR970706799A (cs) |
CN (1) | CN1165478A (cs) |
AT (1) | ATE213625T1 (cs) |
AU (1) | AU700644B2 (cs) |
BR (1) | BR9509720A (cs) |
CA (1) | CA2203512A1 (cs) |
CZ (1) | CZ129597A3 (cs) |
DE (1) | DE69525639T2 (cs) |
DK (1) | DK0788350T3 (cs) |
EE (1) | EE9700214A (cs) |
ES (1) | ES2173204T3 (cs) |
FI (1) | FI118511B (cs) |
HU (1) | HUT77629A (cs) |
IL (1) | IL115878A0 (cs) |
IS (1) | IS4467A (cs) |
NO (1) | NO971986L (cs) |
NZ (1) | NZ295497A (cs) |
PL (1) | PL320425A1 (cs) |
PT (1) | PT788350E (cs) |
SE (1) | SE9403846D0 (cs) |
SK (1) | SK55997A3 (cs) |
TR (1) | TR199501400A2 (cs) |
WO (1) | WO1996014833A1 (cs) |
ZA (1) | ZA959386B (cs) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2736550B1 (fr) * | 1995-07-14 | 1998-07-24 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule |
US6143211A (en) * | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
US7029700B2 (en) * | 2000-01-14 | 2006-04-18 | Brown University Research Foundation | Micronized freeze-dried particles |
AU2001231000A1 (en) | 2000-01-19 | 2001-07-31 | Pharmaceutical Discovery Corporation | Dry powder formulations of antihistamine for nasal administration |
US6977085B2 (en) * | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
US20030096013A1 (en) * | 2000-12-22 | 2003-05-22 | Jane Werling | Preparation of submicron sized particles with polymorph control |
US6951656B2 (en) * | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US6623761B2 (en) | 2000-12-22 | 2003-09-23 | Hassan Emadeldin M. | Method of making nanoparticles of substantially water insoluble materials |
WO2002055059A2 (en) * | 2000-12-22 | 2002-07-18 | Baxter Int | Method for preparing submicron particle suspensions |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
DE10117049A1 (de) * | 2001-04-05 | 2002-10-17 | Novartis Ag | Zusammensetzung |
BR0211028A (pt) * | 2001-06-22 | 2004-06-15 | Pfizer Prod Inc | Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto |
BR0211705A (pt) * | 2001-08-06 | 2004-09-28 | Astrazeneca Ab | Processo para a preparação de uma dispersão estável de partìculas sólidas em um meio aquoso, dispersão estável aquosa, partìcula sólida, composição farmacêutica, método para a inibição do amadurecimento de ostwald em uma dispersão de partìculas sólidas substancialmente insolúveis em água em um meio aquoso, e, uso de um inibidor |
EP1423175B1 (en) * | 2001-08-08 | 2013-10-02 | Brown University Research Foundation | Methods for micronization of hydrophobic drugs |
AU2002337692B2 (en) | 2001-09-26 | 2007-09-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
US20060003012A9 (en) * | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
US20040028747A1 (en) * | 2002-08-06 | 2004-02-12 | Tucker Christopher J. | Crystalline drug particles prepared using a controlled precipitation process |
GB0230088D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
US7511079B2 (en) * | 2003-03-24 | 2009-03-31 | Baxter International Inc. | Methods and apparatuses for the comminution and stabilization of small particles |
JP2006528985A (ja) * | 2003-05-19 | 2006-12-28 | バクスター・インターナショナル・インコーポレイテッド | 1つ以上の界面改変剤でコーティングされた、抗癲癇剤または免疫抑制剤を含有する固体粒子 |
US20060135523A1 (en) * | 2003-06-18 | 2006-06-22 | Astrazeneca Ab | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
GB0314057D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314261D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
US9044381B2 (en) * | 2003-06-24 | 2015-06-02 | Baxter International Inc. | Method for delivering drugs to the brain |
US8986736B2 (en) * | 2003-06-24 | 2015-03-24 | Baxter International Inc. | Method for delivering particulate drugs to tissues |
EP1663321B1 (en) | 2003-09-22 | 2012-08-29 | Baxter International Inc. | High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products |
EP1675571A2 (en) * | 2003-09-30 | 2006-07-05 | Spherics, Inc. | Nanoparticulate therapeutic biologically active agents |
DE10351087A1 (de) * | 2003-10-31 | 2005-05-25 | Bayer Technology Services Gmbh | Feste Wirkstoff-Formulierung |
US20050202094A1 (en) * | 2004-01-29 | 2005-09-15 | Werling Jane O. | Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
EP1711163A2 (en) * | 2004-02-05 | 2006-10-18 | Baxter International Inc. | Dispersions prepared by use of self-stabilizing agents |
JP2008502706A (ja) * | 2004-06-15 | 2008-01-31 | バクスター・インターナショナル・インコーポレイテッド | 固体微粒子治療剤のエキソビボ適用 |
WO2006034147A2 (en) * | 2004-09-16 | 2006-03-30 | Abraxis Bioscience, Inc. | Compositions and methods for the preparation and administration of poorly water soluble drugs |
WO2008135855A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
US8309129B2 (en) * | 2007-05-03 | 2012-11-13 | Bend Research, Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
US8530463B2 (en) * | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
JP2010526822A (ja) * | 2007-05-07 | 2010-08-05 | クエスター ファーマシューティカルズ,インク. | ベンゾジアゼピン類の経鼻投与 |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
EP2162120B1 (en) | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
US8101274B2 (en) * | 2007-06-11 | 2012-01-24 | Spedden Richard H | Solid state membranes with surface-embedded glycosylated amphiphilic molecules and micelles formed therefrom |
GB0714223D0 (en) * | 2007-07-20 | 2007-08-29 | Fujifilm Mfg Europe Bv | Preparation of fine particles |
US9724362B2 (en) | 2007-12-06 | 2017-08-08 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
EP2240162A4 (en) | 2007-12-06 | 2013-10-09 | Bend Res Inc | NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER |
RU2496482C2 (ru) | 2008-03-05 | 2013-10-27 | Бакстер Интернэшнл Инк. | Композиции и способы для доставки лекарственных средств |
ES2586032T3 (es) | 2008-03-28 | 2016-10-11 | Hale Biopharma Ventures, Llc | Administración de composiciones de benzodiazepinas |
CN101278921B (zh) * | 2008-06-03 | 2010-06-09 | 海南百那医药发展有限公司 | 盐酸托烷司琼微囊及其注射剂生产方法 |
US20100151037A1 (en) * | 2008-08-07 | 2010-06-17 | Yivan Jiang | Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound |
US8889168B2 (en) | 2008-08-07 | 2014-11-18 | Bioactive Surgical Inc. | Stem cell capture and immobilization coatings for medical devices and implants |
US10952965B2 (en) * | 2009-05-15 | 2021-03-23 | Baxter International Inc. | Compositions and methods for drug delivery |
CN102784103A (zh) * | 2011-05-16 | 2012-11-21 | 中国科学院上海药物研究所 | 一种通过混合胶束技术制备的普罗布考纳米混悬液及其制备方法 |
WO2012170866A1 (en) * | 2011-06-10 | 2012-12-13 | Norac Pharma | Benzoyl peroxide microparticle process |
ES2917973T3 (es) | 2011-06-14 | 2022-07-12 | Neurelis Inc | Administración de benzodiacepina |
WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
WO2016181406A1 (en) * | 2015-05-08 | 2016-11-17 | Davuluri Ramamohan Rao | Improved process for the preparation of aripiprazole with reduced particle size |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3013839A1 (de) * | 1979-04-13 | 1980-10-30 | Freunt Ind Co Ltd | Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung |
CA1282405C (en) * | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
US4606940A (en) * | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
JPH0249720A (ja) * | 1988-05-18 | 1990-02-20 | Mitsubishi Kasei Corp | 難溶性薬剤組成物 |
SE464743B (sv) * | 1989-06-21 | 1991-06-10 | Ytkemiska Inst | Foerfarande foer framstaellning av laekemedelspartiklar |
IT1243390B (it) * | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
-
1994
- 1994-11-09 SE SE9403846A patent/SE9403846D0/xx unknown
-
1995
- 1995-11-03 EP EP95938091A patent/EP0788350B1/en not_active Expired - Lifetime
- 1995-11-03 EE EE9700214A patent/EE9700214A/xx unknown
- 1995-11-03 BR BR9509720A patent/BR9509720A/pt unknown
- 1995-11-03 HU HU9800181A patent/HUT77629A/hu unknown
- 1995-11-03 KR KR1019970703072A patent/KR970706799A/ko not_active Application Discontinuation
- 1995-11-03 CN CN95196084A patent/CN1165478A/zh active Pending
- 1995-11-03 CZ CZ971295A patent/CZ129597A3/cs unknown
- 1995-11-03 US US08/553,460 patent/US5780062A/en not_active Expired - Lifetime
- 1995-11-03 DK DK95938091T patent/DK0788350T3/da active
- 1995-11-03 AT AT95938091T patent/ATE213625T1/de not_active IP Right Cessation
- 1995-11-03 CA CA002203512A patent/CA2203512A1/en not_active Abandoned
- 1995-11-03 JP JP51597096A patent/JP4098827B2/ja not_active Expired - Fee Related
- 1995-11-03 DE DE69525639T patent/DE69525639T2/de not_active Expired - Lifetime
- 1995-11-03 ES ES95938091T patent/ES2173204T3/es not_active Expired - Lifetime
- 1995-11-03 PT PT95938091T patent/PT788350E/pt unknown
- 1995-11-03 PL PL95320425A patent/PL320425A1/xx unknown
- 1995-11-03 SK SK559-97A patent/SK55997A3/sk unknown
- 1995-11-03 WO PCT/SE1995/001302 patent/WO1996014833A1/en active IP Right Grant
- 1995-11-03 NZ NZ295497A patent/NZ295497A/en unknown
- 1995-11-03 AU AU38851/95A patent/AU700644B2/en not_active Ceased
- 1995-11-06 IL IL11587895A patent/IL115878A0/xx unknown
- 1995-11-06 ZA ZA959386A patent/ZA959386B/xx unknown
- 1995-11-09 TR TR95/01400A patent/TR199501400A2/xx unknown
-
1997
- 1997-04-21 IS IS4467A patent/IS4467A/is unknown
- 1997-04-29 NO NO971986A patent/NO971986L/no unknown
- 1997-05-07 FI FI971947A patent/FI118511B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH10508840A (ja) | 1998-09-02 |
TR199501400A2 (tr) | 1996-06-21 |
NO971986D0 (no) | 1997-04-29 |
ZA959386B (en) | 1996-05-09 |
ES2173204T3 (es) | 2002-10-16 |
SK55997A3 (en) | 1998-01-14 |
PL320425A1 (en) | 1997-09-29 |
ATE213625T1 (de) | 2002-03-15 |
IS4467A (is) | 1997-04-21 |
CN1165478A (zh) | 1997-11-19 |
SE9403846D0 (sv) | 1994-11-09 |
HUT77629A (hu) | 1998-06-29 |
NO971986L (no) | 1997-04-29 |
KR970706799A (ko) | 1997-12-01 |
US5780062A (en) | 1998-07-14 |
JP4098827B2 (ja) | 2008-06-11 |
DK0788350T3 (da) | 2002-04-29 |
EE9700214A (et) | 1998-04-15 |
FI118511B (fi) | 2007-12-14 |
FI971947A (fi) | 1997-05-07 |
PT788350E (pt) | 2002-07-31 |
WO1996014833A1 (en) | 1996-05-23 |
EP0788350B1 (en) | 2002-02-27 |
AU3885195A (en) | 1996-06-06 |
AU700644B2 (en) | 1999-01-14 |
DE69525639T2 (de) | 2002-08-29 |
EP0788350A1 (en) | 1997-08-13 |
NZ295497A (en) | 1998-05-27 |
IL115878A0 (en) | 1996-01-31 |
FI971947A0 (fi) | 1997-05-07 |
BR9509720A (pt) | 1997-10-21 |
DE69525639D1 (de) | 2002-04-04 |
CA2203512A1 (en) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ129597A3 (en) | Process for preparing small particles | |
ZA937081B (en) | Azaquinoxalines processes for their preparation and their use | |
AU2353392A (en) | Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use | |
ZA9610315B (en) | Naphthyl-substituted benzimidazole derivates as anti-coagulants | |
FI971983A0 (fi) | Uudelleendispergoituvat syklodekstriiniä tai syklodekstriinijohdannaisia sisältävät polymeerijauheseokset | |
ES8106705A1 (es) | Procedimiento para la preparacion de derivados de aminoaci- dos | |
SG67935A1 (en) | Novel peptides the preparation and use thereof | |
TR200101286T2 (tr) | Eritromisin'in yeni türevleri, hazırlanma süreçleri ve ilaç olarak kullanımları | |
IL108259A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
EP0833819A4 (en) | N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-YL) -3-AMIDE | |
EP0387821A3 (de) | 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel | |
AU3848595A (en) | Spiro{heterocycle-imidazo{1,2-a}indeno{1,2-e}pyrazine}-4' -ones, preparation thereof and drugs containing same | |
PT628033E (pt) | Derivados de benzodiazepina uteis como antagonistas dos receptores-cck | |
GR3034602T3 (en) | Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides | |
AU2141295A (en) | Indeno{1,2-e}pyrazine-4-ones, preparation thereof and drugs containing same | |
IL144347A0 (en) | Acetylenic sulfonamide thiol tace inhibitors | |
ES2044787A1 (es) | Procedimiento para la proteccion de materiales organicos contra la degradacion por oxidacion, degradacion termica o actinica. | |
NZ527499A (en) | Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus | |
ZA88446B (en) | Allylmercaptoacetylsydnonimines,processes for their preparation, and their use | |
GB9308431D0 (en) | Chemical compounds | |
EA200100810A1 (ru) | Гидроксамовые кислоты на основе ацетиленового арилсульфонамида и амида фосфиновой кислоты, действующие как ингибиторы tace | |
ZA958643B (en) | Pyrrolyltetrahydrobenzoquinoxalinediones their preparation and use | |
NO20023731L (no) | Pulvermaling | |
EP0307553A3 (en) | Acylated splenopentines, their their process of preparation and their use | |
PH31212A (en) | 4-Amino-2-(hetero)aryl-butanamides useful as 5-HT1a-antagonists. |